Nucor (NUE) Misses Q4 EPS by 13c

Nucor (NYSE: NUE) reported Q4 EPS of $1.73, $0.13 worse than the analyst estimate of $1.86. Revenue for the quarter came in at $7.69 billion versus the consensus estimate of $7.87 billion.

For earnings history and earnings-related data on Nucor (NUE) click here.

You May Also Be Interested In

• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Zscaler (ZS) Reiterated at Overweight by Cantor Fitzgerald: Bullish on Red Canary Synergies